Goodwin Procter LLP advised Akero Therapeutics on the deal. Akero Therapeutics closed its million public offering of 6,012,390 shares of common stock at a public offering…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now